DJ-1 in neurodegenerative diseases: Pathogenesis and clinical application-Reference-Cited by-同舟云学术

DJ-1 in neurodegenerative diseases: Pathogenesis and clinical application

Published:2021-09 Issue: Volume:204 Page:102114
ISSN:0301-0082
Container-title:Progress in Neurobiology
language:en
Short-container-title:Progress in Neurobiology

Author:

Huang Maoxin,Chen Shengdi

Funder

National Natural Science Foundation of China

Shanghai Municipal Education Commission

Science and Technology Commission of Shanghai Municipality

Publisher

Elsevier BV

Subject

General Neuroscience

Reference358 articles.

1. Neuroprotective effects of a standardized flavonoid extract from safflower against a rotenone-induced rat model of parkinson’s disease;Ablat;Molecules,2016

2. The role of pathogenic DJ-1 mutations in Parkinson’s disease;Abou-Sleiman;Ann. Neurol.,2003

3. Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington’s disease;Agrawal;Mitochondrion,2019

4. Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity;Ahmad;J. Neurotrauma,2006

5. Gami-chunggan formula prevents motor dysfunction in MPTP/p-Induced and A53T alpha-synuclein overexpressed parkinson’s disease mouse model though DJ-1 and BDNF expression;Ahn;Front. Aging Neurosci.,2019

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New opportunities for antioxidants in amelioration of neurodegenerative diseases;Mechanisms of Ageing and Development;2024-10

2. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides;Current Protein & Peptide Science;2024-09

3. Behavioral screening defines three molecular Parkinsonism subgroups inDrosophila;2024-08-27

4. Glutathione S-transferase polymorphisms (GSTM1/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson’s disease;Journal of Neural Transmission;2024-08-09

5. Protein modification in neurodegenerative diseases;MedComm;2024-08